Skip to content

Amikacin Sulfate Injection 250 mg/mL Single Dose Vials 4 mL x 10/Box Hikma Injectables (RX)

Brand: Hikma Injectables
SKU: 00641-6166-10
Sold out
Original price $ 450.00
Current price $ 325.00
28% OFF
Free Shipping on orders above $120
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Payment Secure transaction
Packaging Ships in product packaging
Sold out
Original price $ 450.00
Current price $ 325.00
Free Shipping on orders above $120
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Payment Secure transaction
Packaging Ships in product packaging
Description

Amikacin Sulfate Injection 250 mg/mL is an antibiotic medication used for the treatment of various bacterial infections. It is commonly used to treat serious infections such as pneumonia, urinary tract infections, sepsis, and certain types of meningitis. This medication is typically only used when other antibiotics have been ineffective, as it may have more serious side effects and should be used with caution. It works by killing or preventing the growth of bacteria in the body.

Amikacin is an injectable aminoglycoside antibacterial used to treat aerobic gram-negative bacterial infections not responsive to more commonly used antibiotics.

Amikacin Sulfate Injection 250 mg/mL by Hikma is a robust, broad-spectrum aminoglycoside antibiotic designed for hospital and clinical environments. Each box contains 10 single-dose 4 mL vials, delivering a powerful 250 mg/mL concentration to combat severe bacterial infections quickly and effectively. Trusted by medical professionals, this prescription injectable assures precise dosing, proven efficacy, and optimal patient safety for serious, life-threatening infections caused by susceptible Gram-negative and some Gram-positive organisms.

Uses

  • Serious Gram-Negative Infections: Effective for septicemia, bacteremia, and hospital-acquired pneumonia.
  • Respiratory Tract Infections: Treats severe cases unresponsive to other antibiotics.
  • Urinary Tract Infections (UTIs): Especially valuable in complicated or resistant cases.
  • Bone, Joint, and Skin Infections: For osteomyelitis, septic arthritis, and complicated skin/soft tissue infections.
  • Intra-abdominal and CNS Infections: Used as part of a multidrug regimen.
  • Other Severe Infections: Such as burn wounds or peritonitis when caused by amikacin-susceptible organisms.

Benefits

  • High Potency Aminoglycoside: Powerful against multi-resistant Gram-negative bacteria, including Pseudomonas and Acinetobacter.
  • Fast-Acting, Reliable Results: Rapid achievement of therapeutic levels for critical care.
  • Flexible Dosing: Convenient 4 mL vials allow for accurate, weight-based dosing in adult and pediatric patients.
  • Single-Dose Sterile Vials: Pre-measured and easy-to-use for reduced contamination risk.
  • Produced by Hikma: A global leader in high-quality hospital and injectable medications.

Directions for Use

  1. Dosage:
    • Individualize dosing based on infection, sensitivity of organism, renal function, and patient body weight.
    • Typical adult dose: 15 mg/kg/day divided every 8–12 hours. Pediatrics: 15–20 mg/kg/day in divided doses.*
  2. Administration:
    • For IV use, dilute appropriately and infuse over 30–60 minutes.
    • For IM use, administer directly into a large muscle mass.
  3. Duration:
    • Administer for 7–10 days or as prescribed based on clinical response and infection severity.
  4. Monitoring:
    • Monitor renal function, auditory function, and peak/trough serum levels to minimize toxicity.

Follow a physician’s prescription and hospital protocols exactly.

Side Effects

Common Side Effects:

  • Pain or swelling at the injection site
  • Headache
  • Fever or rash
  • Nausea/vomiting

Serious/Severe Side Effects (Seek Immediate Medical Attention):

  • Nephrotoxicity (kidney damage): Decreased urination, elevated creatinine/BUN
  • Ototoxicity (hearing or balance problems): Ringing in ears, hearing loss, dizziness
  • Neurotoxic effects: Numbness, muscle twitching, seizures
  • Severe allergic reaction: Rash, swelling, difficulty breathing

Warnings & Precautions

  • Nephrotoxicity & Ototoxicity: Risk increases with prolonged use, high doses, or pre-existing renal impairment.
  • Monitor Drug Levels: Renal function and hearing should be closely monitored during treatment.
  • Use With Caution If: You have kidney impairment, hearing loss, neuromuscular disorders, or are using other nephrotoxic/ototoxic drugs.
  • Contraindicated in known hypersensitivity to amikacin or other aminoglycosides.
  • Pregnancy & Breastfeeding: Use only if clearly needed and prescribed.
  • For hospital/professional administration only. Keep out of reach of children.

Why Choose Amikacin Sulfate Injection by Hikma?

  • High-concentration, hospital-grade antibiotic
  • Fast, reliable results against severe and resistant infections
  • Single-dose, sterile packaging for optimal safety
  • Manufactured by premier injectable specialist Hikma Pharmaceuticals

Order Amikacin Sulfate Injection 250 mg/mL, 4 mL Single Dose Vials x 10/Box by Hikma (NDC: 00641-6166-10) today for trusted, effective, and high-potency antibiotic therapy in your clinical setting!

Description

Amikacin Sulfate Injection 250 mg/mL is an antibiotic medication used for the treatment of various bacterial infections. It is commonly used to treat serious infections such as pneumonia, urinary tract infections, sepsis, and certain types of meningitis. This medication is typically only used when other antibiotics have been ineffective, as it may have more serious side effects and should be used with caution. It works by killing or preventing the growth of bacteria in the body.

Amikacin is an injectable aminoglycoside antibacterial used to treat aerobic gram-negative bacterial infections not responsive to more commonly used antibiotics.

Amikacin Sulfate Injection 250 mg/mL by Hikma is a robust, broad-spectrum aminoglycoside antibiotic designed for hospital and clinical environments. Each box contains 10 single-dose 4 mL vials, delivering a powerful 250 mg/mL concentration to combat severe bacterial infections quickly and effectively. Trusted by medical professionals, this prescription injectable assures precise dosing, proven efficacy, and optimal patient safety for serious, life-threatening infections caused by susceptible Gram-negative and some Gram-positive organisms.

Uses

  • Serious Gram-Negative Infections: Effective for septicemia, bacteremia, and hospital-acquired pneumonia.
  • Respiratory Tract Infections: Treats severe cases unresponsive to other antibiotics.
  • Urinary Tract Infections (UTIs): Especially valuable in complicated or resistant cases.
  • Bone, Joint, and Skin Infections: For osteomyelitis, septic arthritis, and complicated skin/soft tissue infections.
  • Intra-abdominal and CNS Infections: Used as part of a multidrug regimen.
  • Other Severe Infections: Such as burn wounds or peritonitis when caused by amikacin-susceptible organisms.

Benefits

  • High Potency Aminoglycoside: Powerful against multi-resistant Gram-negative bacteria, including Pseudomonas and Acinetobacter.
  • Fast-Acting, Reliable Results: Rapid achievement of therapeutic levels for critical care.
  • Flexible Dosing: Convenient 4 mL vials allow for accurate, weight-based dosing in adult and pediatric patients.
  • Single-Dose Sterile Vials: Pre-measured and easy-to-use for reduced contamination risk.
  • Produced by Hikma: A global leader in high-quality hospital and injectable medications.

Directions for Use

  1. Dosage:
    • Individualize dosing based on infection, sensitivity of organism, renal function, and patient body weight.
    • Typical adult dose: 15 mg/kg/day divided every 8–12 hours. Pediatrics: 15–20 mg/kg/day in divided doses.*
  2. Administration:
    • For IV use, dilute appropriately and infuse over 30–60 minutes.
    • For IM use, administer directly into a large muscle mass.
  3. Duration:
    • Administer for 7–10 days or as prescribed based on clinical response and infection severity.
  4. Monitoring:
    • Monitor renal function, auditory function, and peak/trough serum levels to minimize toxicity.

Follow a physician’s prescription and hospital protocols exactly.

Side Effects

Common Side Effects:

  • Pain or swelling at the injection site
  • Headache
  • Fever or rash
  • Nausea/vomiting

Serious/Severe Side Effects (Seek Immediate Medical Attention):

  • Nephrotoxicity (kidney damage): Decreased urination, elevated creatinine/BUN
  • Ototoxicity (hearing or balance problems): Ringing in ears, hearing loss, dizziness
  • Neurotoxic effects: Numbness, muscle twitching, seizures
  • Severe allergic reaction: Rash, swelling, difficulty breathing

Warnings & Precautions

  • Nephrotoxicity & Ototoxicity: Risk increases with prolonged use, high doses, or pre-existing renal impairment.
  • Monitor Drug Levels: Renal function and hearing should be closely monitored during treatment.
  • Use With Caution If: You have kidney impairment, hearing loss, neuromuscular disorders, or are using other nephrotoxic/ototoxic drugs.
  • Contraindicated in known hypersensitivity to amikacin or other aminoglycosides.
  • Pregnancy & Breastfeeding: Use only if clearly needed and prescribed.
  • For hospital/professional administration only. Keep out of reach of children.

Why Choose Amikacin Sulfate Injection by Hikma?

  • High-concentration, hospital-grade antibiotic
  • Fast, reliable results against severe and resistant infections
  • Single-dose, sterile packaging for optimal safety
  • Manufactured by premier injectable specialist Hikma Pharmaceuticals

Order Amikacin Sulfate Injection 250 mg/mL, 4 mL Single Dose Vials x 10/Box by Hikma (NDC: 00641-6166-10) today for trusted, effective, and high-potency antibiotic therapy in your clinical setting!

Get Notified When Back in Stock